Search Result "extensively drug-resistant tuberculosis (XDR-TB)"
The Evolution of Extensively Drug Resistant Tuberculosis (XDR-TB): History, Status and Issues for Global Control
Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 2 Year: 2007 Page: 73-91
Author(s): Robert C. Goldman, Kevin V. Plumley, Barbara E. Laughon
Epidemiology of Drug Resistant Tuberculosis
Ebook: Drug Resistant Tuberculosis
Volume: 1 Year: 2015
Author(s): Rafael Laniado-LaborÃn
Doi: 10.2174/9781681080666115010003
XDR-TB, What is it; How is it Treated; and why is Therapeutic Failure so High?
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 77-83
Author(s): Stephen H. Gillespie, Kasha Singh
Promising Therapy of XDR-TB/MDR-TB with Thioridazine an Inhibitor of Bacterial Efflux Pumps
Journal: Current Drug Targets
Volume: 9 Issue: 9 Year: 2008 Page: 816-819
Author(s): L. Amaral, M. Martins, M. Viveiros, J. Molnar, J. E. Kristiansen
Stem Cells in MDR-TB and XDR - TB
Journal: Current Respiratory Medicine Reviews
Volume: 10 Issue: 4 Year: 2014 Page: 238-240
Author(s): Vijay K. Arora,Paramjit S. Dhot,P. Singhal
Drug Resistance in Tuberculosis
Ebook: Multi Drug Resistance: A Global Concern
Volume: 1 Year: 2012
Author(s): UD Gupta, Anuj Kumar Gupta
Doi: 10.2174/978160805292911201010100
Treatment of Drug-Resistant Tuberculosis
Ebook: Tuberculosis: A Clinical Practice Guide
Volume: 1 Year: 2020
Author(s): Rafael Laniado-LaborÃn
Doi: 10.2174/9789811488511120010014
Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 5 Issue: 2 Year: 2010 Page: 109-114
Author(s): Leonard Amaral, Joseph Molnar
Biological Basis for Drug Resistant Tuberculosis
Ebook: Drug Resistant Tuberculosis
Volume: 1 Year: 2015
Author(s): Rafael Laniado-LaborÃn
Doi: 10.2174/9781681080666115010005
Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB
Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 6 Issue: 2 Year: 2011 Page: 110-117
Author(s): Marta Martins